Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: September 2008
-
By Donald Zuhn — Last Wednesday, Plaintiffs-Appellees SmithKline Beecham Corp., SmithKline Beecham plc, and Glaxo Group Ltd. (GSK) filed their brief in the Tafas v. Dudas appeal (see "GSK Files Brief in Tafas v. Dudas Appeal"). As we previously reported, the Plaintiffs-Appellees had until September 24th to serve and file their brief. Also…
-
By Christopher P. Singer — The U.S. Patent and Trademark Office issued a press release on September 26, 2008 announcing that it had signed a statement of understanding with the Japanese Patent Office (JPO) which memorializes the existing cooperation between the two Offices and enhances the cooperative efforts on work sharing and international…
-
By Christopher P. Singer — In a September 25, 2008 press release the U.S. Patent and Trademark Office announced that it has entered into an agreement with IP Australia (IPAU), whereby IPAU will act as an International Searching Authority (ISA) and an International Preliminary Examining Authority (IPEA) for certain Patent Cooperation Treaty (PCT)…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Sepracor Inc. and University of Massachusetts v. Pharmaceutical Associates, Inc.3:08-cv-04718; filed September 19. 2008 in the District Court of New Jersey Infringement…
-
October 6-7, 2008 – Patent Litigation 2008 (Practising Law Institute) – McLean, VA October 7-8, 2008 – Global Patent Litigation*** (American Conference Institute) – New York, NY October 15, 2008 – Developments in Pharmaceutical and Biotech Patent Law (Practising Law Institute) – San Francisco, CA October 15-16, 2008 – Pharmaceutical Congress on Paragraph IV Disputes***…
-
By Kevin E. Noonan — Yesterday, we reported on the introduction of a new patent reform bill (S. 3600) in the Senate (see "Senator Kyl’s Patent Reform Bill Introduced Today"). Soon after Senator Jon Kyl’s (R-AZ) patent reform bill was introduced, the Biotechnology Industry Organization (BIO) released a statement in which BIO President…
-
By Donald Zuhn — On Wednesday, SmithKline Beecham Corp., SmithKline Beecham plc, and Glaxo Group Ltd. (GSK) filed their brief in the Tafas v. Dudas appeal (see "Brief of Plaintiffs-Appellees GlaxoSmithKline"). As we previously reported, the Plaintiffs-Appellees had until September 24th to serve and file their brief. Most patent practitioners are no doubt…
-
By Kevin E. Noonan — During this Congress, the biotech and pharma sectors appeared to be caught flat-footed in the face of a concerted effort by information technology companies and their affiliated pressure groups (like the Coalition for Patent Fairness) to "reform" patent law out of effective existence. Not this time: Senator Jon…
-
By Christopher P. Singer — In a memorandum dated September 22, 2008, the U.S. Patent and Trademark Office announced that it and the European Patent Office (EPO) have agreed to enter a pilot Patent Prosecution Highway (PPH) program, effective September 29, 2008, for a term of one year. The addition of the EPO…
-
By Christopher P. Singer — The U.S. Patent and Trademark Office (USPTO) issued a press release on September 24, 2008 announcing that the Office had signed a memorandum of understanding with the Korean Intellectual Property Office (KIPO) regarding a comprehensive plan on cooperative patent examination. The motivation behind this program is to increase…
Patent Docs 